Thesis (M.H.A.)--University of Michigan, 1961.

Thesis (M.P.H.)--University of Michigan, 1946.

Thesis (D.P.H.)--University of Michigan, 1994.

Thesis (M.S.)--University of Michigan, 1994. / Includes bibliographical references.

Thesis (M. Nursing)--Montana State University--Bozeman, 2004. / Typescript. Chairperson, Graduate Committee: Vonna Branam. Includes bibliographical references (leaves 67-71).

Thesis (M.S.)--University of Michigan, 1994. / Includes bibliographical references.

Thesis (Ph.D.)--Ohio University, August, 2005. / Title from PDF t.p. Includes bibliographical references (p. 241-258)

No description available.

The presence of environmental variables associated with the occurrence of podoconiosis was indicated in studies by Price in the 1970s. Observation of red clay soil of volcanic origin and barefoot people in podoconiosis-endemic areas were starting points for investigating these factors. Recently, demonstration of genetic susceptibility to the disease has shown the added value of understanding individual level variations and the presence of gene-environment interactions in the development of podoconiosis. Deeper understanding of which environmental and individual variables determine the development of podoconiosis, and at what spatial scale these variables act, will assist intervention at national and local levels. The present study aims to investigate individual and environmental level variables related to podoconiosis at local scale.

The primary objective of this study was to evaluate the risk of coronary heart disease (CHD) correlated to total homocysteine (tHcy) levels among Hispanics (25.6%) and non-Hispanic whites (74.4%) with type-2 diabetes. The charts of 39 subjects with type-2 diabetes were selected from one physician’s caseload for a convenience sample. This endocrinologist has been supplementing his patients with 1-3 mg of folic acid daily if their tHcy levels were > 13 pmol/L. We found a significant difference (p < .001) between tHcy levels at baseline, follow-up I and follow-up II with a mean total reduction of 4 pmol/L. The results indicated that tHcy levels could be reduced by 1-2 mg folic acid daily in 2-8 months in subjects with type-2 diabetes. The recommendation generated from this study’s findings is that a folic acid supplement be consumed as part of a long-term management regimen for type-2 diabetics.